USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medos International Sarl

USPTO PatentsView assignee record — 535 granted patents across 40 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

535
Total patents granted
40
CPC technology areas
17.9
Avg claims per patent
+134%
5-year filing velocity

Portfolio overview

Medos International Sarl has been granted 535 US utility patents between 2015 and 2025, placing Medos International Sarl at rank #852 across all assignees tracked by PlainPatent. This portfolio spans 40 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Medos International Sarl is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 62.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 375 grants, compared with 160 in the 2015–2019 window — a +134% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medos International Sarl's 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 40 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medos International Sarl against peers pursuing similar technology classes.

How does Medos compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Medos holds 535 patents — placing it at rank #852 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

020406080 20152016201720182019202020212022202320242025 54
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medos International Sarl patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 20 3.7%
2016 22 4.1%
2017 22 4.1%
2018 33 6.2%
2019 63 11.8%
2020 61 11.4%
2021 61 11.4%
2022 68 12.7%
2023 66 12.3%
2024 65 12.1%
2025 54 10.1%

Which technologies does Medos International Sarl patent most?

Top 15 of 40 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#852

Across all tracked assignees

Innovation Score

62.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medos International Sarl hold?
Medos International Sarl holds 535 US granted patents filed between 2015 and 2025, spanning 40 technology areas.
What is Medos International Sarl's Innovation Score?
Medos International Sarl has an Innovation Score of 62.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Medos International Sarl focus on?
Medos International Sarl's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 492 patents. The company has filed patents in 40 CPC subclasses total.
Is Medos International Sarl's patent filing rate increasing or decreasing?
Medos International Sarl's recent filing velocity is +134% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Medos International Sarl's patents?
Medos International Sarl's patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Medos International Sarl patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope